vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与FVCBankcorp, Inc.（FVCB）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.2倍（$16.9M vs $13.7M），FVCBankcorp, Inc.同比增速更快（4377.5% vs 31.1%），FVCBankcorp, Inc.自由现金流更多（$23.8M vs $3.0K），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs 26.9%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
CPIX vs FVCB — 直观对比
营收规模更大
FVCB
是对方的1.2倍
$13.7M
营收增速更快
FVCB
高出4346.4%
31.1%
自由现金流更多
FVCB
多$23.8M
$3.0K
两年增速更快
FVCB
近两年复合增速
26.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $16.9M |
| 净利润 | $-1.4M | — |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 43.7% |
| 净利率 | -10.3% | — |
| 营收同比 | 31.1% | 4377.5% |
| 净利润同比 | 25.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXFVCB
| Q4 25 | $13.7M | $16.9M | ||
| Q3 25 | $8.3M | $416.0K | ||
| Q2 25 | $10.8M | $15.8M | ||
| Q1 25 | $11.7M | $382.0K | ||
| Q4 24 | $10.4M | $378.0K | ||
| Q3 24 | $9.1M | $412.0K | ||
| Q2 24 | $9.8M | $415.0K | ||
| Q1 24 | $8.5M | $359.0K |
净利润CPIXFVCB
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-1.9M | $5.6M | ||
| Q2 25 | $-740.7K | $5.7M | ||
| Q1 25 | $1.3M | $5.2M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.5M | $4.7M | ||
| Q2 24 | $-1.1M | $4.2M | ||
| Q1 24 | $-1.9M | $1.3M |
毛利率CPIXFVCB
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXFVCB
| Q4 25 | -10.0% | 43.7% | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -6.9% | 45.9% | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | -17.7% | — | ||
| Q3 24 | -18.6% | — | ||
| Q2 24 | -10.4% | — | ||
| Q1 24 | -22.0% | — |
净利率CPIXFVCB
| Q4 25 | -10.3% | — | ||
| Q3 25 | -23.4% | 1341.1% | ||
| Q2 25 | -6.8% | 36.0% | ||
| Q1 25 | 10.7% | 1352.1% | ||
| Q4 24 | -18.2% | — | ||
| Q3 24 | -17.0% | 1133.3% | ||
| Q2 24 | -11.0% | 1001.2% | ||
| Q1 24 | -22.9% | 373.3% |
每股收益（稀释后）CPIXFVCB
| Q4 25 | $-0.09 | $0.31 | ||
| Q3 25 | $-0.13 | $0.31 | ||
| Q2 25 | $-0.05 | $0.31 | ||
| Q1 25 | $0.08 | $0.28 | ||
| Q4 24 | $-0.13 | $0.27 | ||
| Q3 24 | $-0.11 | $0.25 | ||
| Q2 24 | $-0.08 | $0.23 | ||
| Q1 24 | $-0.14 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $253.6M |
| 总资产 | $76.8M | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXFVCB
| Q4 25 | $11.4M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.1M | — | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $17.3M | — | ||
| Q1 24 | $18.5M | — |
股东权益CPIXFVCB
| Q4 25 | $24.9M | $253.6M | ||
| Q3 25 | $26.1M | $249.8M | ||
| Q2 25 | $28.0M | $243.2M | ||
| Q1 25 | $28.7M | $242.3M | ||
| Q4 24 | $22.9M | $235.4M | ||
| Q3 24 | $24.8M | $230.8M | ||
| Q2 24 | $26.3M | $226.5M | ||
| Q1 24 | $27.5M | $220.7M |
总资产CPIXFVCB
| Q4 25 | $76.8M | $2.3B | ||
| Q3 25 | $65.9M | $2.3B | ||
| Q2 25 | $67.9M | $2.2B | ||
| Q1 25 | $69.9M | $2.2B | ||
| Q4 24 | $75.6M | $2.2B | ||
| Q3 24 | $76.7M | $2.3B | ||
| Q2 24 | $78.5M | $2.3B | ||
| Q1 24 | $81.5M | $2.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $23.9M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $23.8M |
| 自由现金流率自由现金流/营收 | 0.0% | 140.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $40.0M |
8季度趋势，按日历期对齐
经营现金流CPIXFVCB
| Q4 25 | $3.0K | $23.9M | ||
| Q3 25 | $187.2K | $7.6M | ||
| Q2 25 | $843.8K | $3.3M | ||
| Q1 25 | $3.9M | $5.4M | ||
| Q4 24 | $1.9M | $18.2M | ||
| Q3 24 | $475.5K | $4.7M | ||
| Q2 24 | $-855.7K | $1.6M | ||
| Q1 24 | $-2.1M | $7.2M |
自由现金流CPIXFVCB
| Q4 25 | $3.0K | $23.8M | ||
| Q3 25 | $163.4K | $7.6M | ||
| Q2 25 | $817.3K | $3.3M | ||
| Q1 25 | $3.9M | $5.4M | ||
| Q4 24 | $1.9M | $18.1M | ||
| Q3 24 | $460.1K | $4.6M | ||
| Q2 24 | $-862.8K | $1.5M | ||
| Q1 24 | $-2.2M | $7.1M |
自由现金流率CPIXFVCB
| Q4 25 | 0.0% | 140.7% | ||
| Q3 25 | 2.0% | 1818.0% | ||
| Q2 25 | 7.5% | 20.8% | ||
| Q1 25 | 32.9% | 1413.6% | ||
| Q4 24 | 18.2% | 4786.0% | ||
| Q3 24 | 5.1% | 1121.8% | ||
| Q2 24 | -8.8% | 361.2% | ||
| Q1 24 | -25.6% | 1988.3% |
资本支出强度CPIXFVCB
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.3% | 0.2% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.4% | 4.2% | ||
| Q4 24 | 0.0% | 37.3% | ||
| Q3 24 | 0.2% | 14.1% | ||
| Q2 24 | 0.1% | 12.8% | ||
| Q1 24 | 0.5% | 3.9% |
现金转化率CPIXFVCB
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | 3.10× | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
